Functional Magnetic Resonance Imaging (fMRI) Investigation of Nicotine Withdrawal Symptoms
NCT00657020 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 23
Last updated 2015-03-02
Summary
A single center, double blind, randomized, placebo controlled, two-treatments, two-period crossover study conducted in adult smokers.
Conditions
- Smoking
Interventions
- DRUG
-
Nicotine
Nicotine lozenge containing 4 mg of nicotine
- DRUG
-
Placebo lozenge
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-09-30
- Primary Completion
- 2008-02-29
- Completion
- 2008-02-29
More Related Trials
-
Brain Nicotine Receptor Density in Veteran Smokers
NCT01721473 ·Status: COMPLETED
-
Nicotinic Receptor Levels After Stopping Smoking
NCT01704573 ·Status: COMPLETED
-
Effect of Orexin System on Nicotine Addiction and Its Neural Mechanism
NCT05947162 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Nicotine Withdrawal Symptoms and Smoking Relapse
NCT01511614 ·Status: COMPLETED ·Phase: NA
-
Quantitation of Human Cerebral Nicotinie Receptors With 2[18F]FA-85380 and PET Healthy Non-smokers and Ex-Smokers and in Heavy and Light Situational Smokers
NCT01038245 ·Status: COMPLETED
-
A Study to Examine the Pharmacodynamic Effects of GSK1034702 on Neurophysiological Biomarkers of Cognition in Nicotine Abstained Otherwise Healthy Smokers
NCT01371799 ·Status: COMPLETED ·Phase: PHASE1
-
Brain Reaction to Treatment of Nicotine Dependence
NCT00108173 ·Status: COMPLETED ·Phase: PHASE1
-
An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction
NCT03713424 ·Status: RECRUITING ·Phase: PHASE2
-
Neural Substrates in Nicotine Withdrawal
NCT01001520 ·Status: COMPLETED ·Phase: PHASE2
-
Varenicline on Reward Responses and Cognition in Adolescent Smokers
NCT01624428 ·Status: COMPLETED ·Phase: PHASE1
-
Baclofen Effects in Cigarette Smokers
NCT01821560 ·Status: COMPLETED ·Phase: PHASE2
-
Progesterone and Brain Imaging Study
NCT01954966 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Nicotine on Brain Reward Pathways
NCT02346539 ·Status: COMPLETED ·Phase: PHASE1
-
Tobacco Cessation in Postmenopausal Women (Part II) - 2
NCT00061074 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Varenicline on Blood-Oxygen-Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Activation on Smokers
NCT00934024 ·Status: COMPLETED ·Phase: NA
-
Effect Of Nicotine on Neurocognitive Performance of Cigarette Smokers
NCT00429208 ·Status: UNKNOWN ·Phase: NA
-
Nicotine Metabolizers and [11C]-(+)-PHNO
NCT02514720 ·Status: COMPLETED ·Phase: NA
-
Insular Inhibitory Neuromodulation to Reduce Cigarette Craving and Alter Brain Function in Smokers
NCT02590640 ·Status: COMPLETED ·Phase: NA
-
Electronic Cigarettes and Reactivity to Smoking Cues
NCT01782599 ·Status: RECRUITING ·Phase: NA
-
QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt
NCT04159571 ·Status: COMPLETED ·Phase: NA
-
Measuring Neuroadaptations in Response to Very Low Nicotine Content Cigarettes
NCT03612960 ·Status: COMPLETED ·Phase: NA
-
A Fmri Study on the Effects of a Conjugate Vaccine and Placebo on CNS Activation and Behavior Following a Nicotine Challenge
NCT01318668 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Smoking Abstinence
NCT01035632 ·Status: COMPLETED
-
Nicotine Receptor Levels and Smoking Cessation
NCT01788943 ·Status: COMPLETED
-
Effects of Nicotine on Elements of Attentions in Smokers and Nonsmokers
NCT01034020 ·Status: COMPLETED ·Phase: PHASE1